1. Park JM, Lim HW, Song HS. (2010) Acute Central Horner Syndrome Diagnosed by 0.5% Apraclonidine Test: The Usefulness of the Apraclonidine Test. J Korean Neurol Assoc 28:242-244

2. Park JM, Park JS, Kim YW, Lee HW, Lee DI, Park SP, Song HS. (2011) Unilateral Negative Myoclonus Caused by Herpes Simplex Virus Encephalitis. J Mov Disord. 4:49-52

3. Chung HK, Chung KW, Park JM, Koo HS, Choi KG, Park KD, Choi BO. (2012) Distal Hereditary Motor Neuropathy Type V (dHMN-V) With N88S Mutation in BSCL2 Gene. J Korean Neurol Assoc. 30:333-336

4. Park JM, Seo JG, Park SP. (2012) Validity and Reliability of the Korean Version of the Liverpool Adverse Events Profile (K-LAEP) in People with Epilepsy. Journal of Korean Epilepsy Society. 16:43-48

5. Lee HJ, Park J, Nakhro K, Park JM, Hur YM, Choi BO, Chung KW. (2012) Two novel mutations of GARS in Korean families with distal hereditary motor neuropathy type V. J Peripher Nerv Syst. 17:418-421

6. Park J, Hyun YS, Kim YJ, Nam SH, Hong YB, Park JM, Chung KW, Choi BO. (2013) A novel PRPS1 mutation in a patient with peripheral neuropathy and hearing loss. J Clin Neurol.

7. Nakhro K, Park JM, Choi BO, Chung KW. (2013) Missense mutations of mitofusin 2 in axonal Charcot?Marie?Tooth neuropathy: polymorphic or incomplete penetration? Animal Cells Syst. 17:228-236

8. Nakhro K, Park JM, Kim YJ, Yoon BR, Yoo JH, Koo H, Choi BO, Chung KW. (2013) A novel Lys141Thr mutation in small heat shock protein 22 (HSPB8) gene in Charcot-Marie-Tooth disease type 2L. Neuromuscul Disord. 23:656-663

9. Kim HJ, Hong YB, Park JM, Choi YR, Kim YJ, Yoon BR, Koo H, Yoo JH, Kim SB, Park M, Chung KW, Choi BO. (2013) Mutations in the PLEKHG5 gene is relevant with autosomal recessive intermediate Charcot-Marie-Tooth disease. Orphanet J Rare Dis. 8:104

10. Lee SS, Lee HJ, Park JM, Hong YB, Park KD, Yoo JH, Koo H, Jung SC, Park HS, Lee JH, Lee MG, Hyun YS, Nakhro K, Chung KW, Choi BO. (2013) Proximal dominant hereditary motor and sensory neuropathy is caused by a mutation in TRK fused gene. JAMA Neurol. 70:607-615.

11. Nakhro K*, Park JM*, Hong YB, Park JH, Nam SH, Yoon BR, Yoo JH, Koo H, Jung SC, Kim HR, Kim JY, Choi KG, Choi BO, Chung KW. (2013) SET binding factor 1 (SBF1) mutation causes Charcot-Marie-Tooth disease type 4B3. Neurology. 81:165-173

12. Park JM, Kim YJ, Yoo JH, Hong YB, Park JH, Koo H, Chung KW, Choi BO. (2013) A novel MYH7 mutation with prominent paraspinal and proximal muscle involvements. Neuromuscul Disord. 23:580-586

13. Park JM, Hong YB, Chung KW, Choi BO. (2013) Frequency of causative genes in Korean hereditary peripheral neuropathy patients. J Korean Assoc EMG-Electrodiagn Med. 15:11-19

14. Seo SD, Park HJ, Song HS, Kim HJ, Park JM, Hong YB, Chung KW, Choi BO. (2014) Distal Myopathy with Rimmed Vacuoles Confirmed by Whole Exome Sequencing. Journal of Life Science 24:311-317

15. Park MH, Woo HM, Hong YB, Park JH, Yoon BR, Park JM, Yoo JH, Koo H, Chae JH, Chung KW, Choi BO, Koo SK. (2014) Recessive C10orf2 mutations in a family with infantile-onset spinocerebellar ataxia, sensorimotor polyneuropathy, and myopathy. Neurogenetics. 15:171?182

16. Kim SB, Park JM, Youn MJ, Yoo JH, Choi BO. (2015) Both Symmetric and Asymmetric Muscle Atrophies in a Patient with Facioscapulohumeral Muscular Dystrophy. J Korean Assoc EMG-Electrodiagn Med. 17:50-54

17. Park JM, Kim NK, Park JS. (2016) Pulmonary Thromboembolism after Intravenous Immunoglobulin Therapy in Guillain-Barre Syndrome. Korean J Clin Neurophysiol. 18:14-17

18. Park JM, Lee HC, Park JS. (2017) Remission after Rituximab Therapy in Refractory Myasthenia Gravis. J Korean Neurol Assoc. 35(1):26?29

19. Hong YB*, Park JM*, Yu JS, Yoo DH, Nam DE, Park HJ, Lee JS, Hwang SH, Chung KW, Choi BO. (2017) Clinical characterization and genetic analysis of Korean patients with X-linked Charcot-Marie-Tooth disease type 1. J Peripher Nerv Syst. 22(3):172?181

20. Park JM, Shin JH, Park JS. (2018) GNE Myopathy with Prominent Axial Muscle Involvement. J Clin Neurol. 14(4):580?582

21. Park JM, Lee YJ, Park JS. (2018) A frameshift mutation in the TRPS1 gene showing a mild phenotype of trichorhinophalangeal syndrome type 1. J Genet Med 15(2):97?101

22. Park JM, Nishio H, Shin JH, Park JS. (2019) A Spinal Muscular Atrophy Family with Intrafamilial Phenotype Differences Despite the Same Copy-Number Variation in SMN2. J Clin Neurol. 15(3): 395?397

23. Lee AJ, Nam SH, Park JM, Kanwal S, Choi YJ, Lee HJ, Lee KS, Lee JE, Park JS, Choi BO, Chung KW. (2019) Compound heterozygous mutations of SH3TC2 in Charcot-Marie-Tooth disease type 4C patients. J Hum Genet. 64(9):961?965

24. Cho HJ, Park JM, Park JS. (2019) Improved Bulbar Function in Amyotrophic Lateral Sclerosis after Nuedexta (Dextromethorphan and Quinidine) Treatment. J Korean Neurol Assoc. 37(2): 171?173

25. Park JM, Eah KY. (2019) Recurrent Stroke Due to Antiphospholipid Syndrome Remitted by Immunotherapy, Not by Anticoagulation Therapy: A Case Report and Literature Review. Ann Indian Acad Neurol. 22(2):250?252

26. Park JS, Do YW, Park JM, Seok HY, Park D. (2019) Under-recognized primary spontaneous pneumothorax in ALS: a multicenter retrospective study. Neurol Sci. 40(12):2509?2514

27. Park JM, Kim SY, Park D, Park JS. (2020) Effect of edaravone therapy in Korean amyotrophic lateral sclerosis (ALS) patients. Neurol Sci. 41(1):119-123.

28. Park JM, Lee B, Kim JH, Park SY, Yu J, Kim UK, Park JS. (2020) An autosomal dominant ERLIN2 mutation leads to a pure HSP phenotype distinct from the autosomal recessive ERLIN2 mutations (SPG18). Sci Rep. 10(1):3295.

29. Kim CS, Park JM, Park D, Kim DH, Park JS. (2021) Opioid use may be associated with postoperative complications in myotonic dystrophy type 1 with high-grade muscular impairment. Sci Rep. 11(1):8.

30. Park SY, Park JM, Lee B, Kim UK, Park JS. (2021) A novel REEP1 splicing mutation with broad clinical variability in a family with hereditary spastic paraplegia. Gene. 765:145129.

31. Park JS, Park D, Park JM. (2021) Cancer frequency among the patients with myotonic dystrophy in the South Korean population using the national health insurance database. J Neurol Sci. 420:117212.

32. Park JM, Min YS, Park D, Park JS. (2021) Effect of Nusinersen in a late onset spinal muscular atrophy patient for 14 months: A case report. Medicine (Baltimore). 100(1):e24236.

33. Park JS, Eah KY, Park JM. (2022) Epidemiological profile of myasthenia gravis in South Korea using the national health insurance database. Acta Neurol Scand. 2022 Feb 9.

34. Chang MC, Kwak SG, Park JM, Park D, Park JS. (2022) Clinical and electrophysiological characteristics of respiratory onset amyotrophic lateral sclerosis: a single centre study. Acta Neurol Belg. Mar 31. doi: 10.1007/s13760-022-01936-x.

35. Cho HJ, Shin JH, Park YE, Sohn E, Nam TS, Kang MG, Park JM, Park D, Park JS. (2022) Characteristics of spinal and bulbar muscular atrophy in South Korea: a cross sectional study of 157 patients. Brain. 2022 May 27:awac198.

36. Park JM, Park D, Kim HJ, Park JS. (2022) Long term outcomes of edaravone in amyotrophic lateral sclerosis in South Korea: 72 week observational study. BMC Neurol. 14;22(1):260.